Retatrutide ZPHC — 20 mg (5 vials × 4 mg)

RETATRUTIDE 10 MG KIT by ZPHC PHARMA is a cutting-edge investigational peptide designed to activate three key hormonal receptors:

• GLP-1 (Glucagon-Like Peptide-1)
• GIP (Gastric Inhibitory Polypeptide)
• Glucagon Receptor

This triple-agonist peptide has demonstrated promising effects in early research studies for its ability to support weight management, enhance insulin sensitivity, and improve metabolic performance. It is intended strictly for laboratory research and non-human use.

Key Research Benefits

• Multi-Receptor Activation
  Simultaneously targets GLP-1, GIP & glucagon receptors for synergistic metabolic impact
•  Weight Reduction Support
  Helps reduce food intake and increase fat oxidation
•  Glucose & Insulin Modulation
  Promotes improved glycemic control and insulin function
•  Energy Balance
  May contribute to increased energy expenditure and metabolic flexibility

 Suggested Research Use (For Laboratory Purposes Only)

Retatrutide should be reconstituted with bacteriostatic water prior to subcutaneous administration.

Dosage protocols vary based on study design, species model, and target endpoints.